About the Contest:

  • Open to colleges, universities, biotech companies and pharma companies in the United States with researchers at all career stages
  • Focusing on new Duchenne therapeutics or therapeutic targets, or technology platforms that can help overcome current limitations of Duchenne therapies in development
  • Finalists will have opportunity to pitch their idea to a panel of esteemed judges from the drug development and venture capital communities
  • Email us at Pitch@CureDuchenne.org if you have any questions

The Winning Details:

  • 2 Winners each receiving no-strings attached award of $25,000 by check made out to the winning college, university, or company
  • Access to a wide array of experts in Duchenne drug discovery
  • Ongoing mentoring from CureDuchenne lead scientists Mike Kelly, PhD & Lianna Orlando, PhD

Application Process

First Round:

Fill out application form and upload slide deck

Deadline July 13

Finalists selected
and notified

Week of August 3rd

Finalist round:

Finalists present 15 minute pitch to expert judging panel

August 17-21

Winners publicly

October 2020

Cristina Csimma, PharmD, MHP

Chair of Board of Directors Caraway Therapeutics

Read Bio

Mitchell H. Finer, PhD

Chief Scientific Officer,
President of ElevateBio

Read Bio

Dave Greenwald, PhD

VP President, Business Development
Deerfield Management

Read Bio

Michael G. Kelly, PhD

Chief Scientific Advisor

Read Bio

Adam M. Koppel, MD, PhD

Managing Director
Bain Capital Life Sciences

Read Bio

Walter Kowtoniuk, PhD

Venture Partner
Third Rock Ventures

Read Bio

Martin Lehr

Context Therapeutics

Read Bio

Eric Olson, PhD

Professor & Chairman, Department of Molecular Biology
UT Southwestern Medical Center

Read Bio

Lianna Orlando, PhD

Senior Director of Research

Read Bio

Kush Parmar, MD, PhD

Managing Partner
5AM Ventures

Read Bio

NO PURCHASE OR PAYMENT NECESSARY TO ENTER OR WIN. VOID IN PUERTO RICO AND WHERE PROHIBITED. Entrants must be either (a) an accredited college or university in the 50 United States or District of Columbia, or (b) a biotech or pharma company based in the 50 United States or District of Columbia. See application form, submission requirements, judging criteria, and official rules at CureDuchenne.org/pitchcontest. Entries must be submitted between 12:00 PM Eastern Time on 06/08/2020 and 4:00 PM Eastern Time on 07/13/2020. The two (2) eligible entrants with the most promising ideas in Duchenne Muscular Dystrophy therapy development will each win $25,000. Sponsor: CureDuchenne, located at 1400 Quail Street Suite 110, Newport Beach, CA 92660.

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.